Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.420
+0.090 (2.70%)
At close: Mar 13, 2026, 4:00 PM EDT
3.480
+0.060 (1.75%)
After-hours: Mar 13, 2026, 4:04 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $260.64 million as of March 13, 2026. Its market cap has increased by 158.31% in one year.
Market Cap
260.64M
Enterprise Value
296.33M
1-Year Change
158.31%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $260.64M, a decrease of -80.61%. That is a compound annual growth rate of -13.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 240.80M | -31.22% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 277.68M |
| Inhibikase Therapeutics | 272.20M |
| Abeona Therapeutics | 268.52M |
| C4 Therapeutics | 268.34M |
| OmniAb | 267.85M |
| ALX Oncology Holdings | 265.85M |
| Cibus | 264.15M |
| Ovid Therapeutics | 261.67M |